Wegovy®
A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
- ~16.9% average body weight loss
- Boosts metabolic & cardiovascular health
- Proven, long-established safety profile
- Weekly injection, easy to use

Does tadalafil last all day? Tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor licensed in the UK for erectile dysfunction and benign prostatic hyperplasia, offers notably prolonged effectiveness compared to other treatments. With a half-life of 17.5 hours, a single on-demand dose can provide up to 36 hours of potential effectiveness, whilst daily low-dose regimens maintain continuous coverage. Understanding how long tadalafil works, what influences its duration, and which dosing strategy suits your needs is essential for safe, effective use. This article examines tadalafil's pharmacokinetics, duration of action, and practical considerations for UK patients.
Summary: A single on-demand dose of tadalafil can remain effective for up to 36 hours, whilst daily low-dose tadalafil maintains continuous 24-hour coverage once steady state is reached after approximately five days.
Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor licensed in the UK for the treatment of erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). Understanding its duration of action is essential for patients to use the medication effectively and safely.
The pharmacokinetic profile of tadalafil distinguishes it from other PDE5 inhibitors. After oral administration, tadalafil reaches peak plasma concentrations within approximately two hours. The medication has a notably long elimination half-life of 17.5 hours, meaning it takes this duration for half the drug to be cleared from the bloodstream. This extended half-life translates to a prolonged duration of action, with clinical effects lasting up to 36 hours in many patients.
The body metabolises tadalafil primarily through the hepatic cytochrome P450 3A4 enzyme system, with metabolites excreted predominantly in faeces (61%) and to a lesser extent in urine (36%). This metabolic pathway is important when considering potential drug interactions, particularly with medications that inhibit or induce CYP3A4 activity.
It is important to note that whilst tadalafil remains in the system for an extended period, this does not mean continuous erection or arousal. The medication facilitates the physiological response to sexual stimulation by enhancing nitric oxide-mediated relaxation of smooth muscle in the corpus cavernosum. Sexual stimulation is still required for the medication to produce its therapeutic effect. The extended presence in the system simply means the medication is available to work when needed during this timeframe.
Importantly, tadalafil must never be used with nitrates (including recreational 'poppers') or with riociguat due to the risk of potentially dangerous drops in blood pressure.
Tadalafil's extended duration of action has earned it the description of providing 'weekend' coverage, though whether it truly lasts 'all day' depends on the dosing regimen and individual patient factors.
When taken on-demand, a single dose of tadalafil (typically 10 mg or 20 mg) can provide effective treatment for erectile dysfunction for up to 36 hours. This means that if taken in the morning, the medication may remain effective through the following day and into the next morning. However, this is not the same as continuous 24-hour effectiveness from a single dose taken at the start of each day. On-demand tadalafil should not be taken more than once per day.
Key points about tadalafil's duration:
The 36-hour window represents the period during which the medication can facilitate erectile function in response to sexual stimulation
Effectiveness may gradually diminish towards the end of this period
Individual response varies, with some patients experiencing shorter or longer durations of effect
The medication does not cause constant arousal or erection throughout this timeframe
For patients seeking consistent daily coverage, a low-dose daily regimen (2.5 mg or 5 mg once daily) is available. This approach maintains steady plasma levels of tadalafil, providing continuous readiness without the need to plan medication timing around sexual activity. The daily formulation reaches steady-state concentrations after approximately five days of regular use, after which patients may experience more consistent erectile function support throughout each 24-hour period. This regimen may be more suitable for patients who engage in sexual activity more than twice weekly or who prefer spontaneity without medication planning.
The duration and effectiveness of tadalafil can be influenced by several physiological, lifestyle, and clinical factors that patients and prescribers should consider.
Physiological factors play a significant role in tadalafil metabolism and response. Age affects drug clearance, with older patients potentially experiencing prolonged effects due to reduced hepatic and renal function. Hepatic impairment impacts tadalafil metabolism; for on-demand use, 10 mg may be used with caution in mild to moderate hepatic impairment, but should be avoided in severe hepatic impairment. Once-daily tadalafil is not recommended in any degree of hepatic impairment. Renal function also influences drug clearance; in severe renal impairment (creatinine clearance <30 mL/min), once-daily dosing should be avoided and on-demand dosing limited to 10 mg with caution.
Concomitant medications can substantially alter tadalafil's duration of action. Strong CYP3A4 inhibitors such as ketoconazole, itraconazole, ritonavir, and clarithromycin increase tadalafil plasma concentrations and prolong its effects, necessitating dose reduction. Grapefruit juice may also increase tadalafil levels. Conversely, CYP3A4 inducers like rifampicin, carbamazepine, and phenytoin may reduce tadalafil effectiveness. Alpha-blockers, commonly prescribed for BPH, can interact with tadalafil to cause symptomatic hypotension; avoid non-selective alpha-blockers (particularly doxazosin), ensure stability on alpha-blocker therapy before starting tadalafil, and start at the lowest dose with blood pressure monitoring.
Tadalafil must never be used with nitrates (including recreational amyl nitrite 'poppers') or with riociguat due to the risk of severe, potentially life-threatening hypotension. Nitrates should not be used for at least 48 hours after taking tadalafil.
Lifestyle factors including diet, alcohol consumption, and overall health status influence treatment outcomes. Unlike some PDE5 inhibitors, tadalafil absorption is not significantly affected by food, allowing flexible administration. However, excessive alcohol intake (more than five units) may impair erectile function independently and increase the risk of adverse effects such as dizziness and hypotension. Underlying cardiovascular health, diabetes control, and psychological factors all contribute to individual treatment response.
Patients should avoid tadalafil if sexual activity is inadvisable due to cardiovascular conditions (e.g., recent heart attack or stroke, unstable angina, severe heart failure, uncontrolled arrhythmias, or significant blood pressure issues).
The UK market offers two distinct tadalafil dosing strategies, each with different duration characteristics suited to different patient needs and lifestyles.
On-demand tadalafil (10 mg or 20 mg) is designed for use prior to anticipated sexual activity. Patients should take the medication at least 30 minutes before sexual activity, with effects lasting up to 36 hours. The standard starting dose is 10 mg, which may be increased to 20 mg or decreased to 5 mg based on efficacy and tolerability. Do not take more than one dose per day. This regimen provides up to 36 hours of potential effectiveness from a single dose, making it suitable for patients with less frequent sexual activity (typically fewer than twice weekly). The advantage lies in flexibility and the ability to use medication only when needed, potentially reducing overall drug exposure and cost.
Daily tadalafil (2.5 mg or 5 mg once daily) maintains constant therapeutic levels in the bloodstream. After reaching steady state (approximately five days), patients have continuous medication coverage throughout each day. This approach does not 'last longer' in terms of peak duration but provides consistent, round-the-clock readiness without planning. Daily dosing is not recommended in patients with hepatic impairment or severe renal impairment (creatinine clearance <30 mL/min). Daily dosing may be preferred by patients who:
Engage in sexual activity more than twice weekly
Value spontaneity and dislike planning medication around intimacy
Experience psychological benefits from continuous treatment
Are also being treated for BPH symptoms (5 mg daily dose)
The choice should be individualised based on patient preference, frequency of sexual activity, tolerability, and cost considerations. Some patients may find daily dosing provides more natural erectile function, whilst others prefer the higher-dose, as-needed approach. Both regimens are effective when used appropriately, and patients may trial both under medical supervision to determine optimal treatment.
Remember that tadalafil (in either regimen) must never be used with nitrates or riociguat due to the risk of dangerous drops in blood pressure.
Understanding realistic expectations and potential adverse effects helps patients use tadalafil safely and effectively whilst recognising when medical review is necessary.
Expected therapeutic effects: Tadalafil does not produce automatic erections or increase sexual desire. Sexual stimulation remains necessary for the medication to facilitate erectile function. Most patients notice improved ability to achieve and maintain erections sufficient for sexual intercourse within the medication's active window. Response may improve over the first few doses as patients become accustomed to the medication and anxiety reduces. It is important to recognise that tadalafil treats the physical mechanism of erectile dysfunction but does not address underlying psychological factors, relationship issues, or hormonal imbalances that may contribute to sexual difficulties.
Common adverse effects are generally mild to moderate and often diminish with continued use. These include:
Headache (most common)
Dyspepsia and acid reflux
Back pain and myalgia (typically appearing 12–24 hours after dosing and resolving within 48 hours)
Nasal congestion
Flushing (facial warmth and redness)
When to seek medical attention:
Call 999 or go to A&E immediately if you experience:
Priapism (erection lasting more than four hours) — this constitutes a medical emergency requiring immediate treatment to prevent permanent damage
Sudden vision or hearing loss
Chest pain during sexual activity (do not take nitrates for at least 48 hours after taking tadalafil)
Severe allergic reactions including rash, swelling, or breathing difficulties
Contact your GP or NHS 111 if you experience:
Severe hypotension, particularly if taking alpha-blockers
Persistent or troublesome side effects
Patients should attend regular medication reviews to assess ongoing efficacy, tolerability, and appropriateness of treatment, ensuring tadalafil remains the optimal management strategy for their individual circumstances.
If you experience any suspected side effects, you can report them through the MHRA Yellow Card scheme, which helps monitor the safety of medicines.
A single on-demand dose of tadalafil (10 mg or 20 mg) can provide effective treatment for erectile dysfunction for up to 36 hours, though effectiveness may gradually diminish towards the end of this period. Individual response varies based on factors including age, liver and kidney function, and concomitant medications.
Yes, daily tadalafil (2.5 mg or 5 mg once daily) is available for patients seeking consistent coverage without planning around sexual activity. This regimen reaches steady-state concentrations after approximately five days, providing continuous readiness throughout each 24-hour period, and may be more suitable for those engaging in sexual activity more than twice weekly.
Tadalafil must never be used with nitrates (including glyceryl trinitrate and recreational 'poppers') or riociguat due to the risk of severe, potentially life-threatening hypotension. Strong CYP3A4 inhibitors such as ketoconazole, itraconazole, and ritonavir require dose reduction, whilst alpha-blockers necessitate careful monitoring and dose adjustment to avoid symptomatic hypotension.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript